Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD)
Clinical trial NCT00910897 · UNKNOWN
Trial details
- NCT number
- NCT00910897
- Sponsor
- Intergroupe Francophone du Myelome
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-08-01
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.